Splenectomy in hematologic diseases.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000740:Anemia / Q000628:therapy*; D000741:Anemia, Aplastic / Q000628:therapy; D000743:Anemia, Hemolytic; D000746:Anemia, Hemolytic, Congenital Nonspherocytic / Q000628:therapy; D000925:Anticoagulants; D001854:Bone Marrow Cells; D002648:Child; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007938:Leukemia / Q000628:therapy*; D007945:Leukemia, Lymphoid / Q000628:therapy; D007951:Leukemia, Myeloid / Q000628:therapy; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D055728:Primary Myelofibrosis / Q000628:therapy*; D011696:Purpura, Thrombocytopenic / Q000628:therapy*; D013103:Spherocytosis, Hereditary / Q000628:therapy; D013156:Splenectomy; D013163:Splenomegaly / Q000628:therapy*; D013256:Steroids / Q000627:therapeutic use; D013997:Time Factors
D000925:Anticoagulants; D013256:Steroids; D011241:Prednisone